0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Haemorrhagic occlusive retinal vasculitis associated with intracameral vancomycin during cataract surgery : Letter to the Editor

      1 , 2
      Clinical & Experimental Ophthalmology
      Wiley

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references4

          • Record: found
          • Abstract: found
          • Article: not found

          Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin.

          To describe a syndrome of hemorrhagic occlusive retinal vasculitis (HORV) that developed after seemingly uncomplicated cataract surgery.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Severe bilateral ischemic retinal vasculitis following cataract surgery.

            This report describes two cases of severe, bilateral ischemic retinal vasculitis following cataract surgeries at different surgical centers. In both cases, the patient underwent bilateral cataract surgeries, performed 1 week apart for each eye. In the perioperative period following the second of the two surgeries, both patients developed severe, bilateral intraocular inflammation and profound vision loss. The underlying cause of this adverse response remains unknown. The authors suggest that the severe inflammatory reaction could be related to an intraoperative intracameral vancomycin injection.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Vancomycin-Associated Leukocytoclastic Vasculitis

              Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published. We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin. Skin biopsy revealed leukocytoclastic vasculitis.
                Bookmark

                Author and article information

                Journal
                Clinical & Experimental Ophthalmology
                Clinical & Experimental Ophthalmology
                Wiley
                14426404
                September 2016
                September 2016
                March 29 2016
                : 44
                : 7
                : 635-637
                Affiliations
                [1 ]Caloundra Hospital; Caloundra Queensland Australia
                [2 ]Royal Brisbane and Women's Hospital; Herston Queensland Australia
                Article
                10.1111/ceo.12738
                d69bd751-2a33-4ed1-a6d5-bb7516f5ea59
                © 2016

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article